A first-of-its-kind antiviral gel may offer the potential to stop papillomavirus (HPV) infection before it causes cancer. ( ...
From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...
Genital HPV infections are thought to be responsible for more than 99% of cervical cancers. At least partly because the ...
A new study published Thursday by researchers at the US Centers for Disease Control and Prevention (CDC) highlights the ...
News Medical on MSN3h
First-ever clinical trials evaluate fenofibrate as treatment for HPV-related cancersA team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the ...
Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer ...
The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback